Related Experiment Videos
Therapeutic choice for craniofacial venous malformations
Sadanori Akita1, Kozo Akino, Katsumi Tanaka
1Division of Plastic and Reconstructive Surgery, Nagasaki University, Graduate School of Biomedical and Sciences, 1-7-1 Sakamoto-machi, Nagasaki 8528501, Japan. akitas@hf.rim.or.jp
The Journal of Craniofacial Surgery
|August 1, 2006
Summary
Sclerotherapy is an effective treatment for craniofacial venous malformations, showing significantly less blood loss than surgery. Localized malformations and fewer treatments correlate with excellent outcomes.
Area of Science:
- Vascular Surgery
- Interventional Radiology
Background:
- Craniofacial venous malformations present diagnostic and therapeutic challenges.
- Understanding the precise mechanisms of venous malformations remains limited.
- Clinical manifestations can compromise vital functions like mastication, airway, and phonics.
Observation:
- This study reviewed therapeutic modalities for 11 patients with craniofacial venous malformations (March 1998-February 2006).
- All patients underwent at least one surgical intervention.
- Direct puncture scintigraphy confirmed low-flow malformations in all cases.
Findings:
- Sclerotherapy alone resulted in significantly less blood loss (187 mL) compared to surgery alone (1352 mL) (P < 0.01).
- Excellent sclerotherapy outcomes were associated with localized malformations and fewer treatment sessions (1.3 vs. 3.6 sessions) (P < 0.05).
- Bone surgery and static suspensions were performed in two cases each.
Implications:
- Despite challenges in understanding mechanisms, satisfactory outcomes are achievable with current therapies.
- Further advancements in sclerosants or navigation systems could enhance therapeutic precision and reduce morbidity.
- Multidisciplinary approaches are crucial for managing complex craniofacial venous malformations.